Sorry, you need to enable JavaScript to visit this website.

Our Purpose – Breakthroughs that Change Patients’ Lives – drives us to be a force for good in the world, for everyone, everywhere. Our approach to ESG is embedded in our corporate Purpose Blueprint and Values, which are foundational to how we work to achieve our purpose, build trust, and meet the needs of the patients and communities we serve.

We are committed to building trust and delivering quality and integrity in everything we do. Through our six ESG priority areas – product innovation; equitable access and pricing; product quality and safety; diversity, equity and inclusion; climate change; and business ethics – we are continuously working toward long-term value creation and a sustainable, responsible and patient-centric business model, aligned to our Purpose and Blueprint strategy.

We're setting bold goals aimed at advancing innovation for patients and supporting the search for more sustainable approaches to the discovery and development of our medicines and vaccines.

Why Responsible Business Matters to Pfizer

Our approach to helping address the issues facing our planet and its people is rooted in our purpose — Breakthroughs that change patients’ lives. With patients as our North Star, we embed ESG principles into our core operations to underpin how we fulfill commitments to our patients, shareholders, colleagues, and society alike.

  • Scientist looking through microscope lens

    Reducing cycle times, increasing success rates, and getting more breakthroughs into the hands of patients sooner.

  • Holding hands

    Expanding affordable access to our breakthrough medicines and vaccines and protecting people from the burden of infectious and other diseases.

  • Pfizer lab technician in PPE at a manufacturing plant

    Maintaining a quality culture to ensure the highest priority is placed on the safety, efficacy and reliability of our products, the safety of our patients and consumers, the quality of data supporting regulatory submissions, and interactions with our stakeholders.

  • Business team in a presentation meeting

    Creating opportunities to advance diversity, equity, and inclusion across our workforce, those with whom we do business, and society at large.

    Learn more about Pfizer’s Diversity, Equity, and Inclusion approach.

  • Aerial view of wind turbines and blooming yellow canola field

    Taking action to reduce our greenhouse gas emissions and mitigate risks associated with a changing climate.

  • Business team in a meeting

    Exercising strong corporate governance and risk management practices to promote the long-term interests of our stakeholders.

Connecting our Purpose, Blueprint Strategy, and ESG

Advancing our ESG performance requires cross-company alignment and collaboration. We believe that embedding robust ESG governance into our corporate strategy creates opportunities for mutual reinforcement and impact.

We are integrating ESG purposefully into our ways of working, including strategic decisions, business operations, and governance to increase impact at all levels. While our ESG priorities may evolve over time, we’ll continue to engage regularly with a wide variety of stakeholders. By better understanding their changing needs, interests, and expectations of Pfizer, we can adjust our approach as appropriate.

  • At Pfizer, we measure ourselves by our relentless pursuit of breakthroughs that change patients’ lives. We are dedicated to developing and bringing to market groundbreaking health solutions and taking on the world’s biggest diseases.

  • Patient health and safety are foundational to everything we do. We are committed to high standards of integrity, quality, and safety in our development, manufacturing, and supply through our robust Quality Management System.

  • Every clinical trial is built on trust. We honor that trust by sharing our policies and ensuring clinical trials are planned, conducted, and reviewed to high scientific, ethical, and clinical standards. We are committed to conducting patient-centric clinical trials with populations that reflect the racial and ethnic diversity of the communities we serve.

  • Our pursuit of our purpose drives our innovation and development of medicines and vaccines with high standards of quality and integrity, and accelerating our efforts to bring solutions to those who need them around the world.

  • We set high standards for quality, safety, and integrity throughout our supply chain, because we understand the critical importance of delivering reliable medicines and vaccines to patients and providers worldwide.

  • Our company purpose—Breakthroughs that change patients’ lives—guides our environmental sustainability priorities, with a focus on climate impact mitigation, conservation of resources, and the reduction of waste arising from our operations.

  • To protect our patients, we take a proactive approach to product safety by investing in an enterprise-wide, global strategy to combat counterfeit medicines and vaccines through patient education, legislative advocacy, surveillance, and interdiction.

  • We act with integrity in all we do to fulfill our purpose, and our values guide us in making the right decisions ethically and responsibly so that our business can meet patient and societal needs. Our governance framework emphasizes proactive risk management and leadership accountability.

  • We believe everyone deserves to be seen, heard, and respected for who they are. We live our core value of Equity through our colleague training and development focus, as well as our commitment to Diversity, Equity & Inclusion.

  • We recognize that artificial intelligence (AI) is transforming life sciences and has the potential to improve healthcare for patients across the globe. We have the obligation to use AI ethically, responsibly, and purposefully to advance science and innovation to benefit our patients, customers, colleagues, and society.

  • We are committed to the responsible, transparent, and secure use of personal data entrusted to us by patients, customers, employees, and others.

  • Our colleagues engage with patients and advocacy groups to better understand patient needs, gain insights on experiences, and improve outcomes. We aim to embed the patient perspective in our work from the earliest stages of research to the final approval and use of our medicines and vaccines.

  • Trust is everything. We uphold high ethical, scientific, and medical standards in our research and development activities. We are committed to the responsible promotion our products and transparently reporting on our business practices.

  • In collaboration with advocacy groups and nonprofit partners, we continuously evaluate the language we use around health topics to identify phrasing that is easy to understand and help provide equitable opportunities for health-related decision-making.

  • Where you live shouldn't impact the quality of your healthcare. Therefore, Pfizer has committed to provide its full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to 1.2 billion people living in 45 lower-income countries.

  • We partner with organizations around the world to improve patient access. For example: together with Gavi, the Vaccine Alliance, we continue to supply affordable vaccines to children across the world in low-income countries; Pfizer and the International Trachoma Initiative deliver donated antibiotics toward the elimination of trachoma, the leading infectious cause of blindness worldwide.

  • A cooperative of Pfizer colleagues and more than 40 non-profit partners, The Collective seeks to address health disparities and the systemic drivers of inequitable health outcomes.

ESG Resources

Our resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.

The health of our global environment impacts everyone. At Pfizer, we are committed to reducing our environmental footprint. Our company purpose—Breakthroughs that change patients’ lives—guides our environmental priorities, with a focus on impact reduction, conservation of resources, and the minimization of waste arising from our operations.

At Pfizer, our purpose—Breakthroughs that change patients’ lives—is rooted in achieving social good. We know that when we succeed, our breakthroughs can potentially have life-changing effects. We aim to be the solution for illnesses from widespread infectious diseases to conditions with historically unmet need. Pfizer is mindful of the urgency of our mission, as the world fights against the spread of deadly new diseases and struggles with inequities in health outcomes among populations. Our goal is to leverage partnerships and programs to allow quick and widespread access to our breakthrough medicines and vaccines across all corners of the world.

Ethical decision-making guides us as we work to achieve our purpose of delivering Breakthroughs that change patients’ lives. Through proactive, business-led risk management, Pfizer prioritizes integrity, safety, and quality in every aspect of our business. Our Board of Directors is actively engaged in the governance and oversight of our ESG strategy, which is embedded within our enterprise strategy.

Our ESG Reports provide a comprehensive overview of Pfizer’s commitment to our priority ESG goals toward contributing to long term value creation and a sustainable, responsible, and patient centric business model. Our focus is rooted in our purpose to deliver Breakthroughs that change patients’ lives through ethical decision-making and our core values—Courage, Excellence, Equity, and Joy.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Explore Our CareersDetails